NVE Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by NVE Corporation on June 22, 2026. The filing discloses significant changes to the Company's executive leadership and Board of Directors, effective at the Annual Shareholders' meeting scheduled for August 6, 2026.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and personnel changes.
Material Changes
- Executive Leadership: Daniel A. Baker, Ph.D., will retire as President and Chief Executive Officer (CEO). He will remain on the Board of Directors as Chairman pending shareholder approval.
- New CEO Appointment: Peter G. Eames, currently Vice President of Advanced Technology, is appointed as the new President and CEO effective August 6, 2026. He is also nominated to the Board of Directors.
- Board Nominations: Current Chairman Terence W. Glarner is nominated for re-election. Carolyn W. Valentine, President of Grason-Stadler, is nominated to join the Board and the Compensation and Nominating/Corporate Governance Committees.
- Compensation: Dr. Eames' annual base salary is set at $260,000. His performance-based compensation includes 0.3% of fiscal 2027 income from operations plus 2% of the increase in income from operations in fiscal 2027 compared to fiscal 2026.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. It notes that there are no family relationships or undisclosed arrangements involving the new appointees requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Confirm the election results for the new CEO and board nominees at the August 6, 2026, Annual Shareholders' meeting.
- Review the Company's most recent proxy statement for details on the standard director stock option grants (1,000 shares).
- Monitor future filings for the first financial results under the new CEO's leadership in fiscal 2027.
- Verify the transition plan for Dr. Baker's retirement and his continued role as Chairman.